| Active Ingredient | Fenbendazole |
| Manufacturer | Weefsel Pharma |
| Packaging | 10 X 10 Tablets |
| Strength | 444 Mg |
| Delivery Time | 14-16 Days |
| SKU | Weefen 444 Mg |
| Pack | Price | Qty | Add |
|---|---|---|---|
| 100 Tablets | $80.00 | ||
| 300 Tablets | $180.00 | ||
| 500 Tablets | $320.00 | ||
| 1000 Tablets | $800.00 |
Weefen 444 mg is a higher-strength Fenbendazole antiparasitic tablet produced by Weefsel Pharma. Fenbendazole belongs to the benzimidazole class of anthelmintic compounds with a well-established record of use in veterinary medicine for treating and controlling a broad range of parasitic worm infections.
The 444mg strength is the most widely referenced Fenbendazole tablet strength across veterinary dosing protocols and is one of the most recognized formulations in the Weefen product range by Weefsel Pharma. This strength provides a convenient once-daily dosing option for many commonly referenced treatment protocols as directed by a qualified professional.
Weefsel Pharma produces the Weefen Fenbendazole range across four strengths — 150mg, 222mg, 444mg, and 500mg — to accommodate different dosing and weight-based requirements. The 444mg formulation represents the most commonly requested strength within this range.
Weefen 444mg Tablets are manufactured by Weefsel Pharma, a pharmaceutical manufacturer producing Fenbendazole formulations in certified pharmaceutical facilities. Each production batch undergoes rigorous quality control testing to ensure consistent product purity, potency, and reliability in every tablet supplied.
Fenbendazole demonstrates a significantly stronger binding affinity for parasitic beta-tubulin compared to mammalian beta-tubulin — which is the basis of its selective antiparasitic activity in established veterinary use.
For veterinary use:
For any use under healthcare professional supervision:
There is no established FDA-approved human dosage for Fenbendazole.
In veterinary practice, dosage is individually determined according to:
The Weefen 444 mg strength is the most commonly referenced formulation in many veterinary Fenbendazole dosing protocols and provides a convenient tablet strength for weight-based calculation in adult animals of typical treatment weight ranges.
For any use under healthcare professional supervision, the supervising provider determines the appropriate strength, amount, frequency, and duration based on individual clinical circumstances.
Treatment duration depends entirely on the type of parasitic infection and the professional assessment of the supervising veterinarian or healthcare provider.
A 3-day consecutive daily course is widely referenced in veterinary Fenbendazole protocols for many common parasitic infections. Some conditions may require extended treatment periods or repeated cycles based on follow-up parasitological assessment.
Complete the full prescribed course without stopping early even when visible symptoms appear to resolve. Periodic stool examinations or other follow-up tests may be recommended to confirm successful parasite elimination. Do not discontinue or extend treatment without professional guidance.
If the next scheduled dose is approaching, skip the missed dose and continue the regular prescribed schedule. Seek guidance from the supervising veterinarian or healthcare professional if uncertain about how to proceed.
Most reported effects in veterinary use are mild and temporary.
Commonly noted in veterinary use:
In limited human cases reported under medical supervision:
Do not use Weefen 444 mg in the following situations without professional guidance:
Limited formal drug interaction data exists for Fenbendazole. Based on currently available information:
Always inform the supervising veterinarian or healthcare professional about every medicine, supplement, and product currently in use before starting Weefen 444 mg.
Q: What is Weefen 444 mg used for?
A: Weefen 444 mg is a Fenbendazole-based antiparasitic product used in veterinary practice for treating roundworm, hookworm, whipworm, certain tapeworm, and Giardia infections in animals including dogs, cats, horses, and livestock. Any use outside established veterinary applications must be under direct qualified professional supervision.
Q: Why is Weef en 444mg the most widely referenced Fenbendazole strength?
A: The 444mg strength aligns conveniently with commonly used weight-based veterinary dosing calculations for animals of typical treatment weights. It supports straightforward once-daily dosing in many referenced protocols without requiring tablet splitting, making it the most practically used strength in the Weefen range.
Q: What other strengths does Weefen Fenbendazole come in?
A: Weefsel Pharma produces the Weefen range in four strengths — 150mg for lighter dosing requirements, 222mg as an intermediate option, 444mg as the most commonly used strength, and 500mg as the highest available formulation. Strength selection must always be made by a qualified professional.
Q: Is Weefen 444mg FDA-approved for human use?
A: No. Fenbendazole does not hold FDA approval for any human medical indication. It is classified as a veterinary antiparasitic compound. Any consideration of human use must be under the direct supervision of a qualified healthcare professional only.
Q: How long does a Weefen 444mg treatment course typically last?
A: In veterinary practice, a 3-day consecutive daily course is widely referenced for many parasitic infections. Some conditions require extended or repeated cycles based on follow-up assessment. Duration is always determined by the supervising veterinarian or healthcare professional.
Q: Can Weefen 444mg be given with food?
A: In veterinary use, Fenbendazole may be administered with or without food depending on veterinary recommendations.
Q: What should I do if a dose is missed?
A: Administer the missed dose as soon as possible. If the next scheduled dose is approaching, skip the missed dose and continue the regular schedule. Never administer a double dose. Seek professional guidance if uncertain about how to proceed.
Q: Are there any side effects associated with Weefen 444 mg?
A: In veterinary use, mild digestive upset, temporary appetite loss, diarrhea, and transient lethargy have been noted. In supervised human contexts, nausea, stomach discomfort, dizziness, and elevated liver enzymes have been reported. Seek immediate professional attention for any severe or unexpected adverse reaction.
Q: What is the difference between Weefen 444 mg and Weefen 500 mg?
A: Both are higher-strength Fenbendazole formulations within the Weefen range. The 444mg tablet is the most widely referenced strength in commonly used dosing protocols, while the 500mg tablet is the highest available strength and is used where maximum dose convenience per tablet is required as determined by a qualified professional.
Q: How should Weefen 444 mg Tablets be stored?
A: Store at room temperature below 25°C away from sunlight and moisture in the original 10 x 10 packaging. Keep out of reach of children and pets at all times and do not use past the printed expiry date.
Q: Who manufactures Weefen 444 mg?
A: Weefen 444 mg Fenbendazole Tablets are manufactured by Weefsel Pharma in certified pharmaceutical manufacturing facilities under rigorous quality control standards ensuring consistent tablet potency and purity.
Medical Disclaimer: The information shown above is for educational purposes only. Please consult your doctor or a licensed healthcare professional before taking any medicine. Never start, stop, or change any treatment without professional medical advice.
Reviews
There are no reviews yet.